Clinical CRO
HyBryte™ Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma
Soligenix, Inc.
PR-01-25-NI-10Jan 14, 2025
Cell Therapy
Allogeneic T Cell Therapies: Efficient Commercial Manufacturing Readiness using “Manufacturing by Design” Methodology
Catalent
PAO-12-20-CL-01Dec 16, 2020
Strategic Collaboration
Bayer and Atara Biotherapeutics Enter Strategic Collaboration for Mesothelin-Targeted CAR T-cell Therapies for Solid Tumors
Bayer
PR-M11-20-030Dec 10, 2020
Natural Killer T cells
Combating Cancer and Other Diseases with Supercharged NKT Cells
Theresa Deisher, Ph.D.
AVM Biotechnology
PAP-Q4-20-CL-005Dec 09, 2020
In Conversation
NantKwest — Harnessing Natural Killer Cells to Treat Cancer
Emilie Branch; Patrick Soon-Shiong, M.D.
Pharma's Almanac
PAP-Q1-20-CL-016Mar 19, 2020
T-Cell
Promoting T-Cell Survival
Pharma's Almanac
PAO-M07-19-NI-008Jul 01, 2019
Immunotherapy
Researchers Report SX-682 Could Enhance Multiple Forms of T Cell-Based Immunotherapies in Solid Tumors
Syntrix Pharmaceuticals
PR-M04-19-NI-040Apr 11, 2019
Oncology
Tumor Derived T cells Demonstrate Potential Against Ovarian Cancer
Marc Technow
Nice Insight
PAO-M03-18-NI-020Mar 23, 2018
CAR T
Thermo Fisher Gets Key Customer for Its Cell Therapy Activation Reagents
Nice Insight
PAO-M01-18-NI-006Jan 04, 2018
Drug Development
Memory T Cells Fit to be Cross Trained
Nice Insight
PAO-M12-17-NI-027Dec 19, 2017
Partnership
Magnetic Bead Technology Activates Novartis’ CAR-T Therapy
Nigel Walker
Nice Insight
PAO-M09-17-NI-007Sep 05, 2017
Innovation
Research Collaboration Will Focus on the Development of New CAR T-Cell Treatments
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M07-17-NI-007Jul 07, 2017